ABSTRACT Inflammatory Bowel Disease (IBD) is a chronic immune-mediated inflammatory
disease of the gastrointestinal tract that is a growing public burden. Gut microbes and their …

Low-grade inflammatory diseases revealed metabolic perturbations that have been linked to
various phenotypes, including gut microbiota dysbiosis. In the last decade, metaproteomics …

Metaproteomics can provide valuable insights into the functions of human gut microbiota
(GM), but is challenging due to the extreme complexity and heterogeneity of GM. Data …

Background Metaproteomics is a subfield in meta-omics that is used to characterize the
proteome of a microbial community. Despite its importance and the plethora of publications …

Human SARS-CoV-2 and avian infectious bronchitis virus (IBV) are highly contagious and
deadly coronaviruses, causing devastating respiratory diseases in humans and chickens …

Introduction Gut microbiota alterations have been implicated in Autism Spectrum Disorder
(ASD), yet the mechanisms linking these changes to ASD pathophysiology remain unclear …

The fraction of low-abundance microbiota in the marine environment is a promising target for
discovering new bioactive molecules with pharmaceutical applications. Phenomena in the …

Atopic dermatitis (AD), a prevalent allergic skin condition in children, has been closely
associated with imbalances in the gut microbiome. To investigate these microbial alterations …

Polychlorinated biphenyls (PCBs) exposure is closely associated with the prevalence of
metabolic diseases, including fatty liver and dyslipidemia. Emerging literature suggests that …

Nanomaterial-based enzyme mimetics (nanozymes) have attracted significant interest
because of their lower cost and higher stability compared to natural enzymes. In this study …